IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i21p11360-d667467.html
   My bibliography  Save this article

Value of Active Warming Devices for Intraoperative Hypothermia Prevention—A Meta-Analysis and Cost-Benefit Analysis

Author

Listed:
  • He Xu

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Zijing Wang

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Yijuan Lu

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Xin Guan

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Yue Ma

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Daniel C. Malone

    (College of Pharmacy, University of Utah, Salt Lake City, UT 84101, USA)

  • Jack Warren Salmon

    (College of Pharmacy, University of Illinois Chicago, 833 South Wood Street, Chicago, IL 60612, USA)

  • Aixia Ma

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

  • Wenxi Tang

    (School of International Pharmaceutical Business, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China
    Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, No. 639 Longmian Street, Nanjing 211198, China)

Abstract

Purpose: Historically, studies suggested that intraoperative hypothermia (IH) could result in significant resource consumption, but more recent studies have found the opposite. The purpose of this study is to estimate the value of active warming devices for IH prevention based on synthesized evidence. Methods: A cost-benefit analysis was conducted using the effect of active warming versus passive warming devices for intraoperative hypothermia from a meta-analysis. The item-based aggregated treatment cost approach was adopted to estimate the cost of each adverse event, which was then weighted to calculate the total cost of IH. Results: IH was associated with higher risks of bleeding, surgical site infection, and shivering compared with normothermia. The cost of one case of IH was $363.80, and the use of active warming devices might save $152.80. Extra investment in active warming (e.g., $291.00) might only be cost-beneficial when the minimum willingness-to-pay is $150.00. Conclusions: Synthesized evidence showed that the cost of IH might be overestimated. Furthermore, the value of using active warming devices remains uncertain because the willingness to pay may vary between decision-makers. As not enough awareness of hypothermia prevention in some countries, further research into the clinical use of active warming devices during major surgeries is warranted.

Suggested Citation

  • He Xu & Zijing Wang & Yijuan Lu & Xin Guan & Yue Ma & Daniel C. Malone & Jack Warren Salmon & Aixia Ma & Wenxi Tang, 2021. "Value of Active Warming Devices for Intraoperative Hypothermia Prevention—A Meta-Analysis and Cost-Benefit Analysis," IJERPH, MDPI, vol. 18(21), pages 1-12, October.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:21:p:11360-:d:667467
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/21/11360/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/21/11360/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:21:p:11360-:d:667467. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.